盛弘

0.00 (0.00%)最後更新 2026-09-11

台灣 · 上櫃 · 生技醫療業

18.9075成交張數16.02本益比0.79股價淨值比3.17%殖利率2026-09-11資料日期

ROE 與 ROA

近四季合計;近十年

每股淨值

元

負債比率

負債總額 / 資產總額

現金流量

單季,億元;自由現金流 = 營業現金流 + 資本支出(負值)

季度	資產總額(億)	母公司權益(億)	負債比率	流動比率	每股淨值	ROE(近四季)	ROA(近四季)	營業現金流(億)	自由現金流(億)
2026Q2	65	33	43.5%	1.92	23.97	4.8%	2.4%	1.5	1.4
2026Q1	65	34	41.8%	2.02	24.86	3.7%	1.9%	0.3	0.1
2025Q4	66	34	42.1%	2.00	25.02	4.0%	2.1%	1.1	0.8
2025Q3	68	36	40.6%	2.02	26.23	5.0%	2.6%	1.1	1.0
2025Q2	67	35	42.1%	1.94	26.76	4.7%	2.3%	1.8	1.3
2025Q1	68	36	42.1%	2.00	27.09	5.8%	2.9%	-0.4	-0.7
2024Q4	71	36	43.9%	1.82	27.13	5.7%	2.8%	0.6	0.2
2024Q3	71	35	44.2%	1.78	27.90	4.5%	2.2%	0.7	0.5
2024Q2	74	35	46.2%	1.67	27.96	4.3%	2.1%	1.0	1.0
2024Q1	74	36	45.3%	1.71	28.27	3.2%	1.5%	0.4	0.1
2023Q4	74	35	46.9%	1.65	27.67	3.6%	1.7%	1.0	0.3
2023Q3	74	35	46.2%	1.69	29.10	1.2%	0.5%	1.2	0.9
2023Q2	70	34	44.7%	1.80	28.16	4.3%	2.0%	1.1	0.6
2023Q1	73	35	43.4%	1.88	28.95	6.4%	3.2%	-0.7	-1.7
2022Q4	74	34	44.4%	1.85	28.48	8.9%	4.4%	1.4	0.8
2022Q3	73	34	43.4%	2.12	28.54	13.4%	6.5%	2.8	2.5
2022Q2	76	33	47.1%	2.05	28.76	11.5%	5.3%	2.7	-9.0
2022Q1	62	33	35.7%	2.10	28.59	9.5%	5.0%	-0.6	-0.6
2021Q4	61	31	36.5%	2.14	27.54	7.7%	4.0%	2.9	2.8
2021Q3	60	30	38.9%	1.97	26.39	7.2%	3.8%	-0.0	-0.2
2021Q2	60	29	40.4%	1.93	27.08	10.9%	5.7%	0.1	-0.3
2021Q1	57	30	36.1%	2.01	27.31	12.5%	6.9%	0.6	-0.1
2020Q4	56	29	36.0%	1.93	26.85	9.1%	5.1%	2.8	1.2
2020Q3	52	28	37.8%	1.85	25.81	7.6%	4.2%	2.6	1.5
2020Q2	47	26	37.0%	1.86	25.39	5.8%	3.3%	1.5	0.8
2020Q1	42	24	37.3%	1.77	23.85	5.6%	3.3%	0.3	0.1
2019Q4	42	25	35.9%	1.78	24.53	8.0%	4.8%	1.8	1.5
2019Q3	45	25	39.4%	1.66	24.70	10.0%	5.7%	1.5	1.4
2019Q2	42	24	37.0%	1.84	24.95	8.5%	4.9%	-0.0	-0.1
2019Q1	40	24	35.2%	1.90	24.67	6.5%	3.9%	1.8	1.2
2018Q4	38	24	33.5%	2.19	24.22	6.9%	4.0%	0.0	-0.1
2018Q3	39	23	37.9%	1.84	23.25	4.0%	2.3%	0.1	-0.1
2018Q2	39	23	37.4%	1.82	24.39	4.3%	2.5%	0.2	-0.0
2018Q1	38	23	35.9%	2.00	24.50	5.6%	3.3%	0.0	-0.5
2017Q4	34	19	39.1%	1.42	23.50	6.8%	3.9%	0.2	-0.5
2017Q3	33	19	38.2%	1.50	23.39	7.2%	4.2%	0.6	0.2
2017Q2	32	18	38.5%	1.54	24.05	7.4%	4.3%	0.4	-0.2
2017Q1	31	18	34.9%	1.63	24.33	6.6%	4.1%	-0.6	-0.7
2016Q4	31	18	36.6%	1.59	23.92	–	–	0.2	-0.1
2016Q3	30	18	35.7%	1.57	23.79	–	–	0.7	0.4